Generate Biomedicines, Inc. (GENB)

NASDAQ:GENB

US Market

GENB

Generate Biomedicines, Inc.

RESEARCH TOOLSreports

Want to see GENB full AI Analyst Report?

Generate Biomedicines, Inc. (GENB) Ownership - Who Owns Generate Biomedicines, Inc.?

87 Followers

Generate Biomedicines, Inc. (GENB) Ownership Overview

52.07% Insiders

5.30% Other Institutional Investors

0.52% ETFs

42.11% Public Companies and

Individual Investors

The ownership structure of Generate Biomedicines, Inc. (GENB) stock is a mix of institutional, retail, and individual investors. , 52.07% is owned by Insiders, and 42.11% is owned by Public Companies and Individual Investors.

The ownership structure of Generate Biomedicines, Inc. (GENB) stock is a mix of institutional, retail, and individual investors. Approximately 5.82% of the company’s stock is owned by Institutional Investors, 52.07% is owned by Insiders, and 42.11% is owned by Public Companies and Individual Investors.

Recent Insider Trading Activity

Date	Name	Activity	Value
Mar 06, 2026	Michael Nally	xxxxxxxxxxxxx	$240000
Mar 02, 2026	Noubar Afeyan	xxxxxxxxxxxxx	$75000000
Mar 02, 2026	Jason Silvers	xxxxxxxxxxxxx	$32000
Mar 02, 2026	Beth Grous	xxxxxxxxxxxxx	$4800

Show More Insider Trading Activity >

Recent Hedge Fund Trading Activity

Date	Firm	Activity	Value
Mar 31, 2026	Ark Investment Management Llc	xxxxxxxxxxxxx	$6230100
Mar 31, 2026	Baker Bros Advisors Lp	xxxxxxxxxxxxx	$17795025
Mar 31, 2026	Flagship Pioneering Inc.	xxxxxxxxxxxxx	$783413963
Mar 31, 2026	Harbourvest Partners Llc	xxxxxxxxxxxxx	$21527625

Show More Hedge Fund Trading Activity >

Top Shareholders

Holder	# of Shares	Type	% Holding	Value
Noubar Afeyan	62,673,117	Institution	48.89%	1,017,184,689
	62,673,117	Insider	48.89%	1,017,184,689
	2,889,154	Insider	2.25%	46,890,969
John Toomey, Jr.	1,722,210	Institution	1.34%	27,951,468
Felix Baker	1,423,602	Institution	1.11%	23,105,060
	1,184,989	Insider	0.92%	19,232,371
	515,578	Institution	0.40%	8,367,831
Cathie Wood	498,408	Institution	0.39%	8,089,162
	139,855	Institution	0.11%	2,269,847
	127,210	Institution	0.10%	2,064,618

Top Mutual Fund Holders

Holder	# of Shares	Type	% Holding	Value
	8,500	Institution	<0.01%	137,955

Top ETF Holders

Holder	# of Shares	Type	% Holding	Value
ARK Genomic Revolution ETF	493,109	Institution	0.38%	8,003,159
ALPS Medical Breakthroughs ETF	127,210	Institution	0.10%	2,064,618
Schwab U.S. Small-Cap ETF	121,041	Institution	0.09%	1,867,663
Vanguard Total Stock Market ETF	96,876	Institution	0.08%	1,271,013
Fidelity Nasdaq Composite Index ETF	42,134	Institution	0.03%	650,128
Virtus LifeSci Biotech Clinical Trials ETF	25,106	Institution	0.02%	407,470
Vanguard Extended Market ETF	23,418	Institution	0.02%	307,244
Ark Genomic Revolution Ucits ETF AccumUSD	20,950	Institution	0.02%	323,259
Schwab U.S. Broad Market ETF	18,814	Institution	0.01%	290,300
iShares Morningstar Small-Cap	1,115	Institution	<0.01%	18,096

FAQ

Who Owns Generate Biomedicines, Inc. (GENB)?

According to the latest TipRanks data, approximately 5.30% of the company's stock is held by institutional investors, 52.07% is held by insiders, and 42.11% is held by retail investors.

What percentage of Generate Biomedicines, Inc. (GENB) stock is held by institutional investors?

According to the latest TipRanks data, approximately 5.30% of Generate Biomedicines, Inc. (GENB) stock is held by institutional investors.

What percentage of Generate Biomedicines, Inc. (GENB) stock is held by retail investors?

According to the latest TipRanks data, approximately 42.11% of Generate Biomedicines, Inc. (GENB) stock is held by retail investors.

Who owns the most shares of Generate Biomedicines, Inc. (GENB)?

Noubar Afeyan owns the most shares of Generate Biomedicines, Inc. (GENB).

What is the significance of the ownership structure for a publicly traded company?

The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.